Our Services

Conducting Clinical Research Development Phases

Precision Research conducts and assists through the clinical research development phases while providing patients access to quality healthcare through cutting edge medical research.

  • PHASE 1 Initial Human Trials
    6 months – 1 year
    Objective: Testing the drug on 20 – 80 healthy individuals to determine the drug’s basic safety and pharmacological data.
  • PHASE 2 Expanded Human Trials
    1 – 2 years
    Objective: Testing the drug on around 100 – 200 patients who suffer from the disease or condition the drug is meant to address.
  • PHASE 3a
    2 – 3 years
    Objective: Test the drug with several hundred to several thousand participants at a variety of sites to verify efficacy and safety on a larger scale, with a focus on regulatory issues.Once complete, the drug’s sponsor submits all relevant data as well as plans for producing, packaging, and labeling to local regulatory agencies for review—which can take up to 30 months or more.
  • PHASE 3b
    6 months – 1 year
    Objective: Testing the drug on large groups of patients for cost-effectiveness and efficacy compared with similar, approved drugs.
  • PHASE 4
    Once a drug has received regulatory approval; ongoing
    Objective: Address the safety and efficacy of uses beyond the drug’s original application, test different dosage strengths and formulations, and confirm extra-clinical benefits, such as cost-effectiveness or improved quality of life.

Providing quality training to individuals seeking careers in clinical research.